AbbVie Just Won an FDA First in Parkinson's Disease
AbbVie (ABBV, Financials) won U.S. Food and Drug Administration approval for Juvmo, giving the pharmaceutical company a new Parkinson's disease treatment with a differentiated mechanism.The FDA approved Juvmo, also known as tavapadon, for the treatment of adults with Parkinson's disease.AbbVie said…